Viewing Study NCT01234935

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-05-17 @ 5:55 PM
Study NCT ID: NCT01234935
Status: COMPLETED
Last Update Posted: 2018-01-09
First Post: 2010-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Sponsor: Translational Oncology Research International
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acinar Cell Adenocarcinoma of the Pancreas View
None Duct Cell Adenocarcinoma of the Pancreas View
None Recurrent Pancreatic Cancer View
None Stage IA Pancreatic Cancer View
None Stage IB Pancreatic Cancer View
None Stage IIA Pancreatic Cancer View
None Stage IIB Pancreatic Cancer View
None Stage III Pancreatic Cancer View
Keywords: